CompX International  logo
CompX International CIX
$ 23.68 7.69%

Quarterly report 2025-Q3
added 11-05-2025

report update icon

CompX International Balance Sheet 2011-2025 | CIX

Annual Balance Sheet CompX International

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

- - - - - - -45.4 M -29.7 M -33.2 M -52.3 M -45.6 M -38.8 M -45.3 M 14.1 M

Long Term Debt

- - - - - - - - - - - - 17.5 M 23.2 M

Long Term Debt Current

- - - - - - - - - - - - 1 M -

Total Non Current Liabilities

1.12 M 1.55 M 2.3 M 2.92 M 3.24 M 3.29 M 3.2 M 3.11 M 4.89 M 5 M 7.32 M 6.9 M 23.7 M 38.1 M

Total Current Liabilities

15.8 M 17.2 M 16.7 M 16.4 M 13.2 M 13.1 M 13.7 M 11.3 M 13.3 M 12.1 M 13.2 M 10 M 24.5 M 18.8 M

Total Liabilities

- - - - - - 16.9 M 14.4 M 18.2 M 17.1 M 20.5 M 17 M 48.1 M 56.8 M

Deferred Revenue

97 K 559 K 243 K - 3.24 M - - - - - - - - -

Retained Earnings

92.6 M 115 M 105 M 118 M 112 M 106 M 93.7 M 80.8 M 70.1 M 62.2 M 55.5 M 49.3 M 46.7 M 18 M

Total Assets

163 M 188 M 177 M 192 M 184 M 179 M 166 M 151 M 144 M 135 M 132 M 122 M 150 M 142 M

Cash and Cash Equivalents

60.8 M 41.4 M 26.7 M 76.6 M 70.6 M 63.3 M 45.4 M 29.7 M 33.2 M 52.3 M 45.6 M 38.8 M 63.8 M 10.1 M

Book Value

163 M 188 M 177 M 192 M 184 M 179 M 150 M 137 M 126 M 118 M 111 M 105 M 102 M 84.7 M

Total Shareholders Equity

146 M 169 M 158 M 173 M 168 M 162 M 150 M 137 M 126 M 118 M 111 M 105 M 102 M 84.7 M

All numbers in USD currency

Quarterly Balance Sheet CompX International

2025-Q3 2025-Q2 2025-Q1 2024-Q3 2024-Q2 2024-Q1 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 17 M 17.2 M 17.5 M 17.5 M 17.5 M 17.5 M 23.2 M 23.2 M 23.2 M 23.2 M

Total Non Current Liabilities

900 K 948 K 1.02 M 1.01 M 1.17 M 1.39 M 1.69 M 1.83 M 2.02 M - 2.24 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 6.9 M 6.92 M 23.7 M 23.5 M 23.7 M 23.7 M 23.7 M 23.7 M 38.1 M 38.1 M 38.1 M 38.1 M

Deferred Revenue

50 K 54 K 91 K 98 K 461 K 104 K 574 K 189 K 219 K - 258 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Retained Earnings

84 M 95.8 M 94.1 M 91.8 M 117 M 116 M 112 M 109 M 108 M - 103 M - 120 M 118 M 118 M 116 M 114 M 112 M 112 M 112 M 112 M 106 M 106 M 106 M 106 M 93.7 M 93.7 M 93.7 M 93.7 M 80.8 M 80.8 M 80.8 M 80.8 M 70.1 M 70.1 M 70.1 M 70.1 M 62.2 M 62.2 M 62.2 M 62.2 M 55.5 M 55.5 M 55.5 M 55.5 M 49.3 M 49.3 M 49.3 M 49.3 M 46.7 M 46.7 M 46.7 M 46.7 M 18 M 18 M 18 M 18 M

Total Assets

154 M 165 M 162 M 160 M 185 M 182 M 183 M 179 M 176 M - 177 M - 192 M 192 M 192 M 188 M 184 M 184 M 184 M 184 M 184 M 179 M 179 M 179 M 179 M 166 M 166 M 166 M 166 M 151 M 151 M 151 M 151 M 144 M 144 M 144 M 144 M 135 M 135 M 135 M 135 M 129 M 132 M 132 M 132 M 119 M 122 M 122 M 122 M 150 M 150 M 150 M 150 M 142 M 142 M 142 M 142 M

Cash and Cash Equivalents

46.3 M 56.2 M 56.1 M 58.8 M 70.2 M 51.9 M 17.6 M 18 M 18 M - 53.3 M - 70.2 M 76.6 M 76 M 70.4 M 64.7 M 70.6 M 70.6 M 70.6 M 70.6 M 63.3 M 63.3 M 63.3 M 63.3 M 45.4 M 45.4 M 45.4 M 45.4 M 29.7 M 29.7 M 29.7 M 29.7 M 33.2 M 33.2 M 33.2 M 33.2 M 52.3 M 52.3 M 52.3 M 52.3 M 45.6 M 45.6 M 45.6 M 45.6 M 38.8 M 38.8 M 38.8 M 38.8 M 63.8 M 63.8 M 63.8 M 63.8 M 10.1 M 10.1 M 10.1 M 10.1 M

Book Value

154 M 165 M 162 M 160 M 185 M 182 M 183 M 179 M 176 M - 177 M - 192 M 192 M 192 M 188 M 184 M 184 M 184 M 184 M 184 M 179 M 179 M 179 M 179 M 166 M 166 M 166 M 166 M 151 M 151 M 151 M 151 M 144 M 144 M 144 M 144 M 135 M 135 M 135 M 135 M 129 M 132 M 132 M 132 M 119 M 122 M 122 M 122 M 150 M 150 M 150 M 150 M 142 M 142 M 142 M 142 M

Total Shareholders Equity

138 M 149 M 148 M 145 M 170 M 169 M 165 M 162 M 161 M - 157 M 176 M 175 M 173 M 173 M 171 M 169 M 168 M 168 M 168 M 168 M 162 M 162 M 162 M 162 M 150 M 150 M 150 M 150 M 137 M 137 M 137 M 137 M 126 M 126 M 126 M 126 M 118 M 118 M 118 M 118 M 111 M 111 M 111 M 111 M 105 M 105 M 105 M 105 M 102 M 102 M 102 M 102 M 84.7 M 84.7 M 84.7 M 84.7 M

All numbers in USD currency

Balance Sheet is a fundamental financial report of CompX International , providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.

For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.

Features of balance sheet analysis
  • Vertical and horizontal analysis
    Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods.
  • Asset quality
    It is important to evaluate not only the amount of assets but also their liquidity and realizability.
  • Accounting for off-balance sheet liabilities
    Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.

Balance sheet of other industry stocks – Security protection

Issuer Price % 24h Market Cap Country
BIO-key International BIO-key International
BKYI
$ 0.65 -6.17 % $ 1.34 M usaUSA
Brady Corporation Brady Corporation
BRC
$ 80.73 0.37 % $ 3.85 B usaUSA
Nxt-ID, Inc. Nxt-ID, Inc.
NXTD
- -7.64 % $ 22.6 M usaUSA
Applied DNA Sciences Applied DNA Sciences
APDN
- 31.62 % $ 22.3 M usaUSA
Allegion plc Allegion plc
ALLE
$ 162.92 1.32 % $ 14.2 B usaUSA
Digital Ally Digital Ally
DGLY
$ 1.07 -5.31 % $ 3.8 M usaUSA
MSA Safety Incorporated MSA Safety Incorporated
MSA
$ 161.35 -0.71 % $ 6.35 B usaUSA
NL Industries NL Industries
NL
$ 5.74 -0.61 % $ 280 M usaUSA
The Brink's Company The Brink's Company
BCO
$ 120.1 0.59 % $ 5.32 B usaUSA
Mistras Group Mistras Group
MG
$ 12.5 1.79 % $ 379 M usaUSA
Napco Security Technologies Napco Security Technologies
NSSC
$ 41.62 -1.12 % $ 1.51 B usaUSA
Resideo Technologies Resideo Technologies
REZI
$ 36.2 0.03 % $ 5.29 B usaUSA
SuperCom Ltd. SuperCom Ltd.
SPCB
$ 8.81 -5.83 % $ 15.2 M israelIsrael
Arlo Technologies Arlo Technologies
ARLO
$ 13.46 -4.23 % $ 1.33 B usaUSA
Rekor Systems Rekor Systems
REKR
$ 1.67 -4.57 % $ 145 M usaUSA
VerifyMe VerifyMe
VRME
$ 0.65 -6.05 % $ 6.35 M usaUSA
ADT ADT
ADT
$ 8.2 0.49 % $ 6.72 B usaUSA
Universal Security Instruments Universal Security Instruments
UUU
$ 4.96 4.42 % $ 11.5 M usaUSA
Verra Mobility Corporation Verra Mobility Corporation
VRRM
$ 21.67 -0.6 % $ 3.58 B usaUSA
Vivint Smart Home Vivint Smart Home
VVNT
- -0.04 % $ 2.58 B usaUSA